Article (Scientific journals)
Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Reginster, Jean-Yves; Arden, Nigel K.; Haugen, Ida K. et al.
2018In Seminars in Arthritis and Rheumatism, 48, p. 1-8
Peer Reviewed verified by ORBi
 

Files


Full Text
Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis. consensus of a working group of the ESCEO.pdf
Publisher postprint (230.45 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Clinical trials; Guidelines; Hand osteoarthritis; Pharmacological treatment
Abstract :
[en] OBJECTIVES: To gather expert opinion on the conduct of clinical trials that will facilitate regulatory review and approval of appropriate efficacious pharmacological treatments for hand osteoarthritis (OA), an area of high unmet clinical need. METHODS: The European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal diseases (ESCEO) organized a working group under the auspices of the International Osteoporosis Foundation (IOF) and the World Health Organization (WHO). RESULTS: This consensus guideline is intended to provide a reference tool for practice, and should allow for better standardization of the conduct of clinical trials in hand OA. Hand OA is a heterogeneous disease affecting different, and often multiple, joints of the thumb and fingers. It was recognized that the various phenotypes and limitations of diagnostic criteria may make the results of hand OA trials difficult to interpret. Nonetheless, practical recommendations for the conduct of clinical trials of both symptom and structure modifying drugs are outlined in this consensus statement, including guidance on study design, execution, and analysis. CONCLUSIONS: While the working group acknowledges that the methodology for performing clinical trials in hand OA will evolve as knowledge of the disease increases, it is hoped that this guidance will support the development of new pharmacological treatments targeting hand OA.
Disciplines :
Public health, health care sciences & services
Laboratory medicine & medical technology
Rheumatology
Author, co-author :
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Arden, Nigel K.
Haugen, Ida K.
Rannou, Francois
Cavalier, Etienne  ;  Université de Liège - ULiège > Département de pharmacie > Chimie médicale
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Branco, Jaime
Chapurlat, Roland
Collaud Basset, Sabine
Al-Daghri, Nasser M.
Dennison, Elaine M.
Herrero-Beaumont, Gabriel
Laslop, Andrea
Leeb, Burkhard F.
Maggi, Stefania
Mkinsi, Ouafa
Povzun, Anton S.
Prieto-Alhambra, Daniel
Thomas, Thierry
Uebelhart, Daniel
Veronese, Nicola
Cooper, Cyrus
More authors (12 more) Less
Language :
English
Title :
Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
Publication date :
2018
Journal title :
Seminars in Arthritis and Rheumatism
ISSN :
0049-0172
eISSN :
1532-866X
Publisher :
W. B. Saunders Co., United Kingdom
Volume :
48
Pages :
1-8
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright (c) 2017 The Authors. Published by Elsevier Inc. All rights reserved.
Available on ORBi :
since 23 January 2018

Statistics


Number of views
67 (18 by ULiège)
Number of downloads
6 (6 by ULiège)

Scopus citations®
 
23
Scopus citations®
without self-citations
16
OpenCitations
 
16

Bibliography


Similar publications



Contact ORBi